Up to now, alpha-fetoprotein (α-AFP) has mainly been used in clinic for diagnosis of primary HCC; however, its sensitivity and specificity are not satisfying [29], novel biomarkers for early HCC diagnosis are greatly needed. Here, AFP is linked to hepatocellular carcinoma.